RICHSTONE ELLEN B bought CGTX
June 17, 2026 · Form 4 insider transaction
RICHSTONE ELLEN B bought 25,000 shares of Cognition Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderRICHSTONE ELLEN B
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after83,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.